RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS

被引：0
|
作者：
KIRWAN, JR [1 ]
CURREY, HLF [1 ]
机构：
[1] LONDON HOSP, LONDON E1 1BB, ENGLAND
来源：
CLINICS IN RHEUMATIC DISEASES | 1983年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：581 / 599
页数：19
相关论文
共 50 条
  • [41] Adverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Enrique Machado-Alba, Jorge
    Felipe Ruiz, Andres
    Enrique Machado-Duque, Manuel
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (06): : 396 - 401
  • [42] Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
    Yen, J. -H.
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (10) : 688 - 692
  • [43] Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey
    Bianchi, Gerolamo
    Carletto, Antonio
    Epis, Oscar M.
    Scioscia, Crescenzio
    Semeraro, Angelo
    Donati, Chiara
    Bazzichi, Laura
    Lapadula, Giovanni
    Sinigaglia, Luigi
    Lo Monaco, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [44] Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis
    Rodriguez-Rodriguez, L.
    Jover-Jover, J. A.
    Fontsere, O.
    Pena-Blanco, R. C.
    Leon, L.
    Fernandez-Gutierrez, B.
    Abasolo, L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (06) : 433 - 436
  • [45] Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
    Akter, Ripa
    Maksymowych, Walter P.
    Martin, M. Liam
    Hogan, David B.
    CANADIAN GERIATRICS JOURNAL, 2020, 23 (02) : 184 - 189
  • [46] Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
    Ling-Chun Huang
    Yu-Han Chang
    Yuan-Han Yang
    Neurotherapeutics, 2019, 16 : 703 - 709
  • [47] Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
    Huang, Ling-Chun
    Chang, Yu-Han
    Yang, Yuan-Han
    NEUROTHERAPEUTICS, 2019, 16 (03) : 703 - 709
  • [48] Development of a nursing practice scale for rheumatoid arthritis treatment with biological disease-modifying anti-rheumatic drugs
    Song, Fang
    Nakatani, Hisae
    Sugiyama, Eiji
    Hirata, Shintaro
    MODERN RHEUMATOLOGY, 2024, 34 (03) : 479 - 487
  • [49] PREDICTIVE FACTORS FOR SUCCESSFUL BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS DOSE TAPERING IN RHEUMATOID ARTHRITIS
    Loh, Min Yi
    Jones, Claire J.
    Peall, Adrian
    Trickey, Jeanette
    RHEUMATOLOGY, 2023, 62
  • [50] Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Fan, Junyu
    Jiang, Ting
    He, Dongyi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345